Memantine and Kynurenic Acid: Current Neuropharmacological Aspects.
about
Kynurenine pathway and cognitive impairments in schizophrenia: Pharmacogenetics of galantamine and memantineAn Improved Drugs Screening System Reveals that Baicalein Ameliorates the Aβ/AMPA/NMDA-Induced Depolarization of Neurons.Kynurenic Acid: The Janus-Faced Role of an Immunomodulatory Tryptophan Metabolite and Its Link to Pathological Conditions.
P2860
Memantine and Kynurenic Acid: Current Neuropharmacological Aspects.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Memantine and Kynurenic Acid: Current Neuropharmacological Aspects.
@en
type
label
Memantine and Kynurenic Acid: Current Neuropharmacological Aspects.
@en
prefLabel
Memantine and Kynurenic Acid: Current Neuropharmacological Aspects.
@en
P2093
P2860
P921
P1476
Memantine and Kynurenic Acid: Current Neuropharmacological Aspects.
@en
P2093
József Toldi
Nóra Török
Zsófia Majláth
P2860
P304
P356
10.2174/1570159X14666151113123221
P5008
P577
2015-11-13T00:00:00Z